SEC Form 4 · accession 0001572426-16-000162
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Gearing
Officer — Chief Scientific Officer
Period of report
Feb 25, 2016
Accepted (ET)
Mar 1, 2016 · 2:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Feb 25, 2016 | P | 19,000 | $3.30 | A | 102,664 | I | By DJGearing Pty Ltd <Gearing Family Superannuation Fund A/C> |
| Ordinary SharesF2,F1 | Feb 26, 2016 | P | 12,126 | $3.34 | A | 114,790 | I | By DJGearing Pty Ltd <Gearing Family Superannuation Fund A/C> |
| Ordinary SharesF1 | holding | — | — | — | 279,330 | I | By Gearing Family Pty Ltd <Gearing FamilyA/C> | |
| Ordinary Shares | holding | — | — | — | 5,600 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person and his spouse have shared voting and dispositive power with respect to these reported securities.
- F2Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.35, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.